ID Analysts

Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.

Analyst Articles

SELL TO CLOSE your Simon Property Group (SPG) July 60 Put (SPG+SL) at the market.  As we anticipated, rising interest rates caused the price of SPG stock to go down. On the other hand, consumer spending has been strong, and thus the Simon Property Group, which is also leveraged to consumer spending, can benefit from a temporary support at this level.  Read More

Oil stocks have been under pressure in recent trading as the price of crude has backed away from record highs set a just a few weeks ago. Domestic supply figures have played a role here.  Today, for instance, both the American Petroleum Institute and the Energy Information Administration reported a sizable build in U.S. commercial crude inventories last week.  Read More

BUY TO OPEN May 123 Russell 2000 iShares PUT OPTION (DIW + QS) below 4.20  We advise buying a put on the Russell 2000 iShares (IWM) to capitalize on what we think could be a bearish period for smaller capitalization stocks (Russell 2000 is the most commonly used proxy for small cap stocks).  Read More

Buy to Close your short position on GM   Today, GM shocked the market when the auto giant announced that its full year earnings will be in a range from $1 to $2. Compare this to the January guidance of $4 to $5 and you'll see why the stock is down more than 13% today.  Read More

Sell to close your March 45 Newmont Mining call option (NEM+CI) at the market. The yellow metal has been acting well of late and a result has pushed our call option into the money. But while the stock is higher now than when we entered the trade, the option's time value has eroded away, handing us a loss on the trade.  Read More

Buy Amylin Pharmaceuticals (AMLN) on margin.  the company expects to hear from the FDA regarding its smaller drug, Symlin; and on April 30th- regarding its drug exenatide. We expect at least one of these approvals to come through, and the stock price to react accordingly.  Because of the leverage, the trade is rated Medium Risk. Read More